Literature DB >> 8207211

Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo.

K Fecho1, K A Maslonek, M E Coussons-Read, L A Dykstra, D T Lysle.   

Abstract

The present study examined the role of macrophage-derived nitric oxide in the suppressive effect of in vivo morphine administration on Con A-stimulated proliferation of splenic lymphocytes in rats. The results showed that concentrations of nitrite are significantly greater in Con A-stimulated splenocyte cultures from morphine-treated rats than in cultures from saline-treated rats, and that the depletion of macrophages from splenocyte cultures abolishes the suppressive effect of morphine on Con A-stimulated proliferation. Moreover, the addition of NG-monomethyl-L-arginine (NMMA) to Con A-stimulated splenocyte cultures attenuates the suppressive effect of morphine on mitogenic responsiveness. The addition of excess L-arginine to splenocyte cultures containing NMMA reverses the effect of NMMA and restores morphine's suppressive effect on Con A-stimulated proliferation, but the addition of D-arginine to splenocyte cultures containing NMMA does not restore the suppressive effect of morphine. Taken together, these findings demonstrate that the suppressive effect of in vivo morphine administration on Con A-stimulated proliferation of splenic lymphocytes involves macrophage-derived nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207211

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 2.  The presence of endogenous morphine signaling in animals.

Authors:  George B Stefano; Patrick Cadet; Richard M Kream; Wei Zhu
Journal:  Neurochem Res       Date:  2008-09-06       Impact factor: 3.996

Review 3.  Effects of opioids on the immune system.

Authors:  S Roy; H H Loh
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

4.  Avian reovirus induces an inhibitory effect on lymphoproliferation in chickens.

Authors:  S Neelima; G C Ram; J M Kataria; T K Goswami
Journal:  Vet Res Commun       Date:  2003-01       Impact factor: 2.459

5.  Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus.

Authors:  Z Xing; K A Schat
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.

Authors:  H Tomioka; W W Maw; K Sato; H Saito
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

7.  Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase.

Authors:  D T Lysle; K A Carrigan
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

8.  Morphine potentiates neuropathogenesis of SIV infection in rhesus macaques.

Authors:  Sirosh M Bokhari; Ramakrishna Hegde; Shannon Callen; Honghong Yao; Istvan Adany; Qingsheng Li; Zhuang Li; David Pinson; Hung-Wen Yeh; Paul D Cheney; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-24       Impact factor: 4.147

Review 9.  Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology.

Authors:  George B Stefano; Richard M Kream; Kirk J Mantione; Melinda Sheehan; Patrick Cadet; Wei Zhu; Thomas V Bilfinger; Tobias Esch
Journal:  Semin Cancer Biol       Date:  2007-12-08       Impact factor: 15.707

10.  Morphine-induced enhancement in the granulocyte response to thioglycollate administration in the rat.

Authors:  Karamarie Fecho; Donald T Lysle
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.